An Open-Labeled Trial of Ramelteon in Idiopathic Rapid Eye Movement Sleep Behavior Disorder | Zendy

Yuichi Esaki | Zendy; Tsuyoshi Kitajima | Zendy; Shigefumi Koike | Zendy; Hiroshige Fujishiro | Zendy; Yasuyo Iwata | Zendy; Akiko Tsuchiya | Zendy; Marina Hirose | Zendy; Nakao Iwata | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

An Open-Labeled Trial of Ramelteon in Idiopathic Rapid Eye Movement Sleep Behavior Disorder

Author(s) -

Yuichi Esaki,

Tsuyoshi Kitajima,

Shigefumi Koike,

Hiroshige Fujishiro,

Yasuyo Iwata,

Akiko Tsuchiya,

Marina Hirose,

Nakao Iwata

Publication year - 2016

Publication title -

journal of clinical sleep medicine

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.529

H-Index - 92

eISSN - 1550-9397

pISSN - 1550-9389

DOI - 10.5664/jcsm.5796

Subject(s) - fujita scale , sleep medicine , medicine , psychiatry , psychology , family medicine , sleep disorder , geography , cognition , meteorology

Rapid eye movement (REM) sleep behavior disorder (RBD) is a parasomnia characterized by REM sleep without atonia and elaborate motor activity in association with dream mentation. The melatonin receptor agonist ramelteon has been documented as being effective in two patients with secondary RBD. However, there are no reports on ramelteon treatment for idiopathic RBD.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research